News - Sobi, Kineret

Filter

Current filters:

SobiKineret

Popular Filters

SOBI reveals strong sales in third quarter

SOBI reveals strong sales in third quarter

30-10-2013

Swedish Orphan Biovitrum has published its third quarter results revealing that total revenues were 517.3…

EuropeFinancialKineretOrfadinPharmaceuticalSobi

FDA approves SOBI's Kineret for the treatment of NOMID

08-01-2013

Biotech firm Swedish Orphan Biovitrum (STO: SOBI) today announced that the US Food and Drug Administration…

AmgenBiotechnologyInflammatory diseasesKineretNorth AmericaRegulationSobiSwedish Orphan Biovitrum

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top